Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the second quarter ended June 30, 2024. The company showcased notable revenue growth and significant strategic …
TELA Bio Announces Second Quarter 2024 Financial Results and Strategic Developments Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently approved inducement grants of restricted stock units for nine newly-hired employees. The grants cover 16,000 shares of common stock and have …
TELA Bio Announces Inducement Grants for New Employees Read More MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) announced the appointment of Jeffrey Blizard, Global Head of Surgical Sales at Abiomed, to its Board of Directors. This move, effective June …
TELA Bio Appoints Jeffrey Blizard to Board, Strengthening Sales Expertise Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of Greg Firestone as the company’s new Chief Commercial Officer. Firestone will oversee commercial operations, including key product launches, …
TELA Bio Appoints Greg Firestone as Chief Commercial Officer Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a significant player in the medical device industry, has announced the award of restricted stock units (RSUs) to eleven new employees as …
TELA Bio Awards Stock Units to New Employees as Hiring Inducement Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently disclosed its first-quarter financial results for 2024, showcasing significant growth and strategic advancements. The company reported a revenue of $16.6 million, …
TELA Bio Reports Strong First Quarter Growth, Expands Product Portfolio Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading innovator in the medical device sector, announced this week the U.S. launch of its latest product, OviTex IHR (Inguinal Hernia …
TELA Bio Launches Innovative Hernia Repair Device in the U.S. Market Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) this week announced the appointment of Howard N. Langstein, MD, FACS, as Vice President of Medical Affairs and Surgeon Strategy. This decision …
TELA Bio Appoints Esteemed Surgeon Dr. Howard N. Langstein as Vice President of Medical Affairs Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently revealed its financial performance for both the fourth quarter and the full calendar year ending on December 31, 2023. A cumulative …
TELA Bio Stands Tall With Consistent Growth, Novel Products, and a Promising Revenue Projection for 2024 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leader in the development of medical devices for soft tissue reconstruction, has made a significant stride in surgical innovation with the …
TELA Bio Introduces Revolutionary Hernia Mesh Fixation Devices in the U.S., Aiming to Transform Surgical Practices Read More